Orange Book product · Generic (ANDA)
FLUVOXAMINE MALEATE
FLUVOXAMINE MALEATE
At a glance
Apr 30, 2026
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 30, 2026
2 mo ago
Today
Pharmaceutical detail
Active ingredient
FLUVOXAMINE MALEATE
Strength
100MG
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
TE code
AB
Application
ANDA 220328
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of FLUVOXAMINE MALEATE
- 2008LUVOX CRBrand (NDA)
NDA 022033 · JAZZ PHARMS
- 2007LUVOXBrand (NDA)
NDA 021519 · ANI PHARMS
- 1994LUVOXBrand (NDA)
NDA 020243 · SOLVAY
- 2025FLUVOXAMINE MALEATEGeneric (ANDA)
ANDA 217024 · ANNORA PHARMA
- 2024FLUVOXAMINE MALEATEGeneric (ANDA)
ANDA 219055 · AJANTA PHARMA LTD
- 2024FLUVOXAMINE MALEATEGeneric (ANDA)
ANDA 217917 · BIONPHARMA
- 2020FLUVOXAMINE MALEATEGeneric (ANDA)
ANDA 212182 · BIONPHARMA
- 2014FLUVOXAMINE MALEATEGeneric (ANDA)
ANDA 203240 · TORRENT
- 2013FLUVOXAMINE MALEATEGeneric (ANDA)
ANDA 091482 · ACTAVIS ELIZABETH
- 2013FLUVOXAMINE MALEATEGeneric (ANDA)
ANDA 091476 · PH HEALTH
- 2006FLUVOXAMINE MALEATEGeneric (ANDA)
ANDA 075900 · CHARTWELL RX
- 2002FLUVOXAMINE MALEATEGeneric (ANDA)
ANDA 075893 · TEVA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
